NCT04067661

Brief Summary

This project seeks to test the efficacy of a couples-based HIV prevention program in large-scale randomized controlled trial (RCT) to reduce HIV risk among transgender woman and their partners. This project involves enrolling a racially diverse sample of transgender women and their partners and randomizing 50 couples to either the couples-based HIV prevention intervention or an enhanced standard of care (SOC) control condition. Couples will be followed quarterly over 12-months. Analysis of study outcomes will utilize both individual- and dyadic-level data. The primary outcome is a composite measure of risk for HIV transmission which encompasses validated behavioral indicators of HIV risk as well as biomedical confirmation of viral suppression and PrEP adherence.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P25-P50 for not_applicable hiv-infections

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

August 6, 2025

Completed
Last Updated

August 6, 2025

Status Verified

July 1, 2025

Enrollment Period

4.5 years

First QC Date

August 22, 2019

Results QC Date

June 26, 2025

Last Update Submit

July 16, 2025

Conditions

Keywords

HIV PreventionTransgender WomenIntervention

Outcome Measures

Primary Outcomes (2)

  • Condomless Sex

    Self-report condomless anal or vaginal sex with any partner in the past 3 months

    Changes in self-reported condomless anal or vaginal sex at 12-month follow-up

  • Composite HIV Risk

    We created a composite measure incorporating self-reported condomless sex, PrEP adherence, and viral suppression, resulting in a binary HIV risk outcome (1=yes, 0=no). Participants reporting condomless sex in the past 30 days, along with either lack of viral suppression or non-adherence to PrEP, were categorized as at HIV risk. Conversely, those who did not report condomless sex, were virally suppressed, or were adherent to PrEP were placed in the not at HIV risk group. The variable was constructed such that 1= HIV Risk versus 0 = No HIV Risk. The results below represent the number of participants who were categorized as 1 = HIV risk at the 12-month follow up.

    12 months

Study Arms (2)

Intervention

EXPERIMENTAL

Participants and their partners will complete four couples counseling sessions focused on developing and enhancing relationship skills to decrease HIV risk behaviors.

Behavioral: CHIP

Control

ACTIVE COMPARATOR

Participants and their partners will receive information and referrals on HIV risk and prevention strategies.

Behavioral: Control

Interventions

CHIPBEHAVIORAL

The couples-based HIV prevention intervention consists of four couples counseling sessions focused on relationship skills to decrease HIV risk behaviors.

Also known as: It Takes Two
Intervention
ControlBEHAVIORAL

Enhanced standard of care, which includes information and referrals on HIV risk and prevention.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Self-report that they are in emotional and/or sexual relationship for at least three months
  • One partner must identify as a trans women (assigned the male gender at birth but identify as female or as a trans woman)
  • Both partners must have engaged in condomless sex within the past 6 months with any partner
  • Able to provide informed consent
  • Speak and read English

You may not qualify if:

  • Currently psychotic, suicidal, or manic
  • Either partner reports that participating in the study would cause them physical harm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94158, United States

Location

Related Publications (3)

  • Gamarel KE, Chakravarty D, Neilands TB, Hoff CC, Lykens J, Darbes LA. Composite Risk for HIV: A New Approach Towards Integrating Biomedical and Behavioral Strategies in Couples-Based HIV Prevention Research. AIDS Behav. 2019 Jan;23(1):283-288. doi: 10.1007/s10461-018-2229-8.

  • Sevelius JM, Gutierrez-Mock L, Zamudio-Haas S, McCree B, Ngo A, Jackson A, Clynes C, Venegas L, Salinas A, Herrera C, Stein E, Operario D, Gamarel K. Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic. AIDS Behav. 2020 Jul;24(7):2009-2012. doi: 10.1007/s10461-020-02920-3. No abstract available.

  • Gamarel KE, Sevelius JM, Neilands TB, Kaplan RL, Johnson MO, Nemoto T, Darbes LA, Operario D. Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention. BMJ Open. 2020 Oct 15;10(10):e038723. doi: 10.1136/bmjopen-2020-038723.

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Kristi Gamarel
Organization
University of Michigan

Study Officials

  • Ellen Stein

    University of California, San Francisco

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study involved a randomized controlled trial comparing the couples-based HIV prevention to an enhanced standard of care control condition
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 22, 2019

First Posted

August 26, 2019

Study Start

November 1, 2019

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

August 6, 2025

Results First Posted

August 6, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

We will compile structured de-identified datasets and can make them available for additional/secondary data analyses. For data sharing, the research team will follow the "standards for privacy of individually identifiable health information." Participants' records and results will not be identified. No contact information will be included in any archived datasets.

Locations